Development: Beyond Contract Manufacturing - How Manufacturing Relationships are now a Competitive Advantage

The rise of biologics has introduced manufacturing complexity that didn't exist a decade ago. Monoclonal antibodies, stem cell therapies and mRNA platforms all demand specialist capability, and the CDMO market is consolidating around it. We'll explore how manufacturing is moving from a back-office function to a strategic differentiator, and what that means for the make-vs-buy decision at every stage of development.